logo

FDA Calendar

Share
Company Name Biogen Inc.
Drug Name Aducanumab (BLA)
Event Name FDA decision on Aducanumab for Alzheimer's Disease
Event Date 03/07/2021
Outcome Date
Outcome
Drug Status Priority Review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar